Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zydena in subcortical vascular cognitive impairment
NCT01466543Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Nov 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of udenafil in Mild Cognitive Impairment (MCI), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
udenafil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01466543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466543.